NCT06176443View on ClinicalTrials.gov

Impact of an Increased Restrictive Factor of One Anastomosis Gastric Bypass on Metabolic Outcomes Type 2 Diabetes.

NACompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

January 13, 2024

Study Completion Date

May 1, 2024

Conditions

Obesity, MorbidDiabetes Mellitus, Type 2

Interventions

PROCEDURE

One anastomosis gastric bypass with combined fundoplication

FundoRingOAGB

PROCEDURE

One anastomosis gastric bypass without combined fundoplication

OAGB

Trial Locations (1)

010000

Oral Ospanov, Astana

All Listed Sponsors

lead

The Society of Bariatric and Metabolic Surgeons of Kazakhstan

OTHER

NCT06176443 - Impact of an Increased Restrictive Factor of One Anastomosis Gastric Bypass on Metabolic Outcomes Type 2 Diabetes. | Biotech Hunter | Biotech Hunter